Ozdemir, M. Et Al. 2003. Assessment of CYP2D6 in vivo activity: relative sensitivity of urinary metabolic ratios of debrisoquine (DB), dextromethorphan (DM) and metoprolol (MP) to urine pH. Conference of the British-Pharmacological-Society-Clinical-Pharmacology-Section , (London, Canada), 686.

Ozdemir, M., Aktan, Y., Rostami-Hodjegan, A., Crewe, H., & Tucker, G., (2003). Assessment of CYP2D6 in vivo activity: relative sensitivity of urinary metabolic ratios of debrisoquine (DB), dextromethorphan (DM) and metoprolol (MP) to urine pH . Conference of the British-Pharmacological-Society-Clinical-Pharmacology-Section (pp.686). London, Canada

Ozdemir, M Et Al. "Assessment of CYP2D6 in vivo activity: relative sensitivity of urinary metabolic ratios of debrisoquine (DB), dextromethorphan (DM) and metoprolol (MP) to urine pH," Conference of the British-Pharmacological-Society-Clinical-Pharmacology-Section, London, Canada, 2003

Ozdemir, M Et Al. "Assessment of CYP2D6 in vivo activity: relative sensitivity of urinary metabolic ratios of debrisoquine (DB), dextromethorphan (DM) and metoprolol (MP) to urine pH." Conference of the British-Pharmacological-Society-Clinical-Pharmacology-Section , London, Canada, pp.686, 2003

Ozdemir, M. Et Al. (2003) . "Assessment of CYP2D6 in vivo activity: relative sensitivity of urinary metabolic ratios of debrisoquine (DB), dextromethorphan (DM) and metoprolol (MP) to urine pH." Conference of the British-Pharmacological-Society-Clinical-Pharmacology-Section , London, Canada, p.686.

@conferencepaper{conferencepaper, author={M Ozdemir Et Al. }, title={Assessment of CYP2D6 in vivo activity: relative sensitivity of urinary metabolic ratios of debrisoquine (DB), dextromethorphan (DM) and metoprolol (MP) to urine pH}, congress name={Conference of the British-Pharmacological-Society-Clinical-Pharmacology-Section}, city={London}, country={Canada}, year={2003}, pages={686} }